Relistor
Active substance: methylnaltrexone
TABLET · METHYLNALTREXONE BROMIDE 150 mg/1
United StatesActive
Marketing holder: Salix Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- METHYLNALTREXONE BROMIDE · 150 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-afb4-7bec-b424-584a73690f2c,01a12090-89c5-703c-b67a-3f278af2d0aa,01a12096-e8af-7cf3-b829-3e36fac5c6e6;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 65649-150
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 65649-150 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 65649-150 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 65649-150 · Verified 2026-10-09 · open in source